PGx Firm AssureRx Raises $12.5M in Series C Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Pharmacogenomics firm AssureRx Health announced on Wednesday it has closed its Series C financing, raising $12.5 million.

The funding will go toward commercialization of its GeneSightRx Psychotropic and GeneSightRx ADHD tests as well as the development of new tests, the Mason, Ohio-based company said. AssureRx President and CEO James Burns added that the proceeds will be used to expand sales coverage, sponsor multiple clinical studies, and develop new products "to help accelerate our leadership position in psychiatric personalized medicine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.